Wang et al. generated a 99mTc-labeled anti-CEACAM5 VHH, which rapidly accumulated in lung cancer H460 xenografts in vivo assessed by γ-counting, but did not show target specificity [28]. Here, CEACAM5 is linked to lung cancer.